← Back to Search

Post-operative Adaptive Radiation Therapy for Prostate Cancer

N/A
Waitlist Available
Led By Charles N Catton, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial will study the side effects of radiation therapy for prostate cancer by asking 20 subjects to fill out surveys about their quality of life and toxicity scores.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in radiation dose delivered to target volumes and normal tissue
Secondary outcome measures
Time for radiotherapy replanning
Toxicity associated with the adaptive radiotherapy technique.
Volumetric modulated arc therapy impact in a clinical adaptive Radiotherapy workflow.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Post-Operative adaptive radiotherapyExperimental Treatment1 Intervention
All Patients enrolled in this study will have additional scans (Cone-Beam CT, MRI) daily during their treatment. This extra imaging will help us see any changes that might have occurred during radiation treatment and update the treatment plan to include these changes before patient treatment is continued.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Post-operative Adaptive Radiation Therapy
2013
N/A
~30

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,489 Previous Clinical Trials
489,743 Total Patients Enrolled
64 Trials studying Prostate Cancer
15,479 Patients Enrolled for Prostate Cancer
Charles N Catton, MDPrincipal InvestigatorThe Princess Margaret Cancer Foundation

Media Library

Post-operative Adaptive Radiation Therapy Clinical Trial Eligibility Overview. Trial Name: NCT02034955 — N/A
Prostate Cancer Research Study Groups: Post-Operative adaptive radiotherapy
Prostate Cancer Clinical Trial 2023: Post-operative Adaptive Radiation Therapy Highlights & Side Effects. Trial Name: NCT02034955 — N/A
Post-operative Adaptive Radiation Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT02034955 — N/A
~2 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top